Skip to content
Menu

Purple Biotech Q3 EPS $(0.60) Beats $(2.88) Estimate

Benzinga Newsdesk 4 days ago

NewsEarningsEarnings Beats

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Purple Biotech (NASDAQ:PPBT) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(2.88) by 79.17 percent. This is a 79.02 percent increase over losses of $(2.86) per share from

Purple Biotech (NASDAQ:PPBT) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(2.88) by 79.17 percent. This is a 79.02 percent increase over losses of $(2.86) per share from the same period last year.

Read at benzinga.com

← All stock news